Searched for
MEL SPIGELMAN
Lupin, TB Alliance join hands for new therapy for drug-resistant tuberculosisTB Alliance President and CEO Mel Spigelman said that partnering with Lupin -- a well-established manufacturer with experience delivering h...06 Sep, 2021, 12.53 PM IST- BPaL regimen can cut time for treatment of drug-resistant TBBPaL is a six-month, alloral, three-drug regimen that is used to treat people with highly drug-resistant forms of TB. It consists of the TB...22 Jul, 2021, 10.28 AM IST
- Mylan gets DCGI nod for anti-tuberculosis drug Pretomanid for conditional accessThe Drug Controller General of India (DCGI) has approved Pretomanid for conditional access under the National Tuberculosis Elimination Prog...22 Jul, 2020, 04.02 PM IST
- Mumbai pharma company gets licence for breakthrough TB drugA global non-profit drug developer TB Alliance has tied up with domestic company Macleods Pharmaceuticals to develop and commercialise its ...28 Oct, 2019, 10.14 AM IST
- States must invest in R&D to fund new drug discoveries: TB AllianceGeneric manufacturers are essential players in the fight to end TB so we do speak with generic manufacturers as part of our access strategy.26 Sep, 2018, 06.08 PM IST
- Drug combo speeds up TB treatmentThe drug combination, known as PaMZ, killed more bacteria than standard treatment and was effective in treating drug-resistant tuberculosis.21 Jul, 2014, 05.38 PM IST
Load More
